NorthWest Biotherapeutics Inc (NWBO)

[Investor082]

The problem is none of those future PRs (after UK approval) will be earth shattering or even meaningful from a shareholder perspective by any means. There will be no non dilutive cash attached to any of those combo or Direct deals. So where they will find the money to run these trials? Just their normal ongoing operations and so on require about 150M shares in dilution per year (as reflected from 2024). And that does not even include investment in building a team to commercialize L in the UK. Forget about RA submissions in EU and Canada and all the associated costs there. I just don’t think any of the trials will get off the ground in 2025 due to funding issues. So the markets will simply dismiss the future events as they did with Roswell Park announcement and others. Shorts might pounce on the UK approval spike because they know there will be ton of dilution in 2025 and beyond.

LP has simply dangled a carrot to recruit more bag holders post UK approval. Their long, rich history is indicative of a nothing burger. Also, that’s the reason why making those announcements now will have no effect on the share price since there will be no non dilutive cash attached to any of those deals. Hence, markets will dismiss it anyway. At least, holding it back after UK approval gives her an opportunity to create a hook for shareholders to stay on post UK approval!